ISABELLA PAYA: Open Payments
NPI 1568236313 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$495 in 24 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $587 · 2025 $495
Food & beverage: $495
| Company | Payments | Amount |
|---|---|---|
| Exact Sciences Corporation | 4 | $77 |
| Daiichi Sankyo Inc. | 3 | $72 |
| Ardelyx, Inc. | 2 | $58 |
| AstraZeneca Pharmaceuticals LP | 3 | $51 |
| Amgen Inc. | 2 | $42 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $41 |
| Lilly USA, LLC | 2 | $36 |
| Novo Nordisk Inc | 2 | $36 |
| C2N Diagnostics, LLC | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
Products named: INJECTAFER, IBSRELA, Cologuard Collection Kit, REPATHA, XIFAXAN, The Cologuard Plus Collection Kit, PRECIVITYAD2, ZEPBOUND.
Industry payments across FL — which companies pay providers there.
